跳至主要内容
临床试验/NCT03929822
NCT03929822终止不适用

Contrast-Enhanced Spectral Mammography: Potential to Improve Diagnostic Accuracy

Memorial Sloan Kettering Cancer Center1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2019年4月23日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
32
试验地点
1
主要终点
Diagnostic accuracy of CESM compared to mammography

研究概览

简要总结

The purpose of this study is to test whether contrast-enhanced spectral mammography (CESM) may be able to reduce the number of unnecessary biopsies in women whose screening mammograms had abnormal findings.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women called back from a screening mammography by either FFDM or tomosynthesis with soft tissue abnormalities including masses, asymmetries, focal asymmetries or architectural distortion with or without calcifications. Patients will be questioned regarding the possibility of pregnancy and will need a negative pregnancy test prior the study intervention.

排除标准

  • Age <30 years old
  • Screening mammography with only calcifications abnormalities
  • Male patients
  • Pregnant or lactating patients
  • Patients with any allergy to iodinated contrast
  • Patients with eGFR < 45
  • Patients that may be treated with radioactive iodine

结局指标

主要结局

Diagnostic accuracy of CESM compared to mammography

时间窗: 2 years

The radiologist will interpret the low energy images and record their findings.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验